Transcriptome Analysis Identifies Oncogenic Tissue Remodeling during Progression from Common Nevi to Early Melanoma
The American Journal of Pathology · 2023
DOI: 10.1016/j.ajpath.2023.03.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Pathology, 2023. Verfasst von Amin Zia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Orlucent, Inc., Los Gatos, California. Hauptthemen laut MEDLINE: Melanoma, Nevus, Skin Neoplasms, Dysplastic Nevus Syndrome. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Orlucent, Inc., Los Gatos, California.
- Department of Bioengineering: Bioinformatics, University of California, San Diego, San Diego, California.
- Orlucent, Inc., Los Gatos, California. Electronic address: cshachaf@orlucent.com.
Zitieren
APA
Zia, A., Litvin, Y., Voskoboynik, R., Klein, A., & Shachaf, C. (2023). Transcriptome Analysis Identifies Oncogenic Tissue Remodeling during Progression from Common Nevi to Early Melanoma. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2023.03.016
Vancouver
Zia A, Litvin Y, Voskoboynik R, Klein A, Shachaf C. Transcriptome Analysis Identifies Oncogenic Tissue Remodeling during Progression from Common Nevi to Early Melanoma. The American Journal of Pathology. 2023. doi:10.1016/j.ajpath.2023.03.016
BibTeX
@article{Zia2023,
author = {Zia, Amin and Litvin, Yoav and Voskoboynik, Ronnie and Klein, Amit and Shachaf, Catherine},
title = {Transcriptome Analysis Identifies Oncogenic Tissue Remodeling during Progression from Common Nevi to Early Melanoma},
journal = {The American Journal of Pathology},
year = {2023},
doi = {10.1016/j.ajpath.2023.03.016}
}
EUVIMED